In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
Dileep R. Yavagal, MD, Professor of Neurology & Neurosurgery and Chief Interventional Neurologist at the University of Miami – Miller School of Medicine, describes a treatment that has…
NEW YORK (Reuters Health) – Giving abciximab to high-risk patients with ST-elevation myocardial infarction (STEMI) before transferring them for percutaneous coronary intervention (PCI) reduces 1-year mortality without increasing…
NEW YORK (Reuters Health) – Using hypertonic saline with nebulized epinephrine instead of normal saline does not improve the clinical outcomes of infants in the ER with mild…
NEW YORK (Reuters Health) – Interest in off-pump coronary artery bypass grafting (CABG) grew in the mid-1990s based on the belief that it could reduce the complications seen…
NEW YORK (Reuters Health) – In patients with stable angina pectoris, the heart-rate lowering drug ivabradine reduces attack frequency and nitrate consumption – and this is true even…
NEW YORK (Reuters Health) – Long-term treatment with low-dose trimethoprim-sulfamethoxazole is modestly effective in preventing urinary tract infections (UTI) in predisposed children, according to a report in The…
NEW YORK (Reuters Health) – Phenothiazines are more effective than other agents, including opioids, for the treatment of acute migraine, according to a meta-analysis published in the October…
NEW YORK (Reuters Health) – Weight gain and metabolic problems complicate use of second-generation antipsychotic medications by children and adolescents, investigators report in the October 28 issue of…
NEW YORK (Reuters Health) – Although diclofenac is commonly used to treat acute pain in children, it is not licensed for this purpose in all age groups. A…
NEW YORK (Reuters Health) – Adult survivors of childhood cancer, particularly those in poor physical health, are at increased risk for suicidal thoughts, according to an October 19…
NEW YORK (Reuters Health) – A secondary analysis of a previous study provides functional data that further supports the benefits of alteplase therapy when given up to 4.5…
